VLS Retatrutide 20mg Triple G Research Pen

VLS Retatrutide 20mg Triple G

The VLS Retatrutide 20mg Triple G is listed by the supplier as a retatrutide product in an injection pen format. Retatrutide is an investigational compound being studied for its potential effects on body weight and metabolic health.

About Retatrutide

Retatrutide is described as a triple hormone receptor agonist because it acts on three pathways: GIP, GLP-1, and glucagon. These pathways are involved in metabolic processes, including appetite-related signaling and glucose regulation.

Researchers are studying retatrutide in clinical trials to evaluate its safety and potential effects in people with obesity and other metabolic conditions. However, it has not been approved by the FDA for general public use, and it should not be presented as an established or approved weight-loss medicine.

Product Details

• Brand listed by supplier: VLS
• Compound: Retatrutide
• Listed strength: 20mg
• Listed format: Injection pen kit
• Product descriptor: Triple G

The supplied information does not independently verify the product's identity, formulation, concentration, purity, manufacturing standards, or regulatory authorization. Confirm these details with reliable documentation before publishing.

Important Safety and Regulatory Information

Retatrutide is investigational, and its safety and efficacy are still being evaluated. Products sold outside authorized clinical trials may have uncertain contents, purity, concentration, and quality.

Do not rely on seller claims about appetite suppression, insulin sensitivity, metabolic health, or long-term weight management as established benefits of this specific product. Do not use unapproved products as substitutes for authorized medicines or professional medical care.

This description is for general informational purposes and does not provide dosage instructions or constitute medical advice.